Intellia Therapeutics, Inc. (NTLA)
9.14
+0.12
(+1.33%)
USD |
NASDAQ |
Dec 15, 16:00
8.99
-0.15
(-1.64%)
After-Hours: 05:08
Intellia Therapeutics Research and Development Expense (Annual): 456.03M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 44.58M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Beam Therapeutics, Inc. | 367.56M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Pacific Biosciences of California, Inc. | 129.02M |